Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chrysoula Boutari

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Life (Basel, Switzerland)|March 29, 2023
Novel Dual Endothelin Inhibitors in the Management of Resistant HypertensionChrysoula Boutari, Fotios Siskos
Metabolism: Clinical and Experimental|May 18, 2022
A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage onChrysoula Boutari, Christos S Mantzoros
International Journal of Molecular Sciences|February 27, 2026
Genetic Predisposition to MASLD: Potential for Therapeutic ManagementFani Karapanagiotidi, Chrysoula Boutari, Emmanouil Sinakos
Diabetes Research and Clinical Practice|June 25, 2023
Obesity and diabetesChrysoula Boutari, Antea DeMarsilis, Christos S Mantzoros
Expert Review of Cardiovascular Therapy|June 9, 2021
Rosuvastatin and ezetimibe for the treatment of dyslipidemia and hypercholesterolemiaChrysoula Boutari, Asterios Karagiannis, Vasilios G Athyros
Expert Opinion on Pharmacotherapy|June 16, 2021
Ertugliflozin + metformin as a treatment option for type 2 diabetesVasilios G Athyros, Chrysoula Boutari, Asterios Karagiannis
Endocrinology and Metabolism (Seoul, Korea)|March 29, 2018
Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver DiseaseChrysoula Boutari, Nikolaos Perakakis, Christos Socrates Mantzoros
Current Pharmaceutical Design|August 6, 2025
FGF21 Analogues and MASLD: A Summary of Preclinical and Clinical DataChrysoula Boutari, Achilleas Triantafyllou, Lavrentis Papalavrentios, et al.
World Journal of Nephrology|July 14, 2015
Erectile dysfunction in chronic kidney disease: From pathophysiology to managementEirini Papadopoulou, Anna Varouktsi, Antonios Lazaridis, et al.
Clinical Nutrition (Edinburgh, Scotland)|September 9, 2022
Statins' efficacy in non-alcoholic fatty liver disease: A systematic review and meta-analysisChrysoula Boutari, Panagiotis D Pappas, Dimitrios Anastasilakis, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Life (Basel, Switzerland)|March 29, 2023
Novel Dual Endothelin Inhibitors in the Management of Resistant HypertensionChrysoula Boutari, Fotios Siskos
Metabolism: Clinical and Experimental|May 18, 2022
A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage onChrysoula Boutari, Christos S Mantzoros
International Journal of Molecular Sciences|February 27, 2026
Genetic Predisposition to MASLD: Potential for Therapeutic ManagementFani Karapanagiotidi, Chrysoula Boutari, Emmanouil Sinakos
Diabetes Research and Clinical Practice|June 25, 2023
Obesity and diabetesChrysoula Boutari, Antea DeMarsilis, Christos S Mantzoros
Expert Review of Cardiovascular Therapy|June 9, 2021
Rosuvastatin and ezetimibe for the treatment of dyslipidemia and hypercholesterolemiaChrysoula Boutari, Asterios Karagiannis, Vasilios G Athyros
Expert Opinion on Pharmacotherapy|June 16, 2021
Ertugliflozin + metformin as a treatment option for type 2 diabetesVasilios G Athyros, Chrysoula Boutari, Asterios Karagiannis
Endocrinology and Metabolism (Seoul, Korea)|March 29, 2018
Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver DiseaseChrysoula Boutari, Nikolaos Perakakis, Christos Socrates Mantzoros
Current Pharmaceutical Design|August 6, 2025
FGF21 Analogues and MASLD: A Summary of Preclinical and Clinical DataChrysoula Boutari, Achilleas Triantafyllou, Lavrentis Papalavrentios, et al.
World Journal of Nephrology|July 14, 2015
Erectile dysfunction in chronic kidney disease: From pathophysiology to managementEirini Papadopoulou, Anna Varouktsi, Antonios Lazaridis, et al.
Clinical Nutrition (Edinburgh, Scotland)|September 9, 2022
Statins' efficacy in non-alcoholic fatty liver disease: A systematic review and meta-analysisChrysoula Boutari, Panagiotis D Pappas, Dimitrios Anastasilakis, et al.
Pageof 4